Hatoum, Alexander S.Davis, Christal N.Kember, Rachel L.Johnstone, MandyOslin, David W.Zinkstok, Janneke R.Burmeister, MargitEthics, Position, and Public Policy Committee of the International Society of Psychiatric GeneticsBoard of Directors of the International Society of Psychiatric GeneticsAgrawal, ArpanaKranzler, Henry R.Edenberg, Howard J.Gelernter, JoelDocherty, Anna R.Lencz, Todd2025-07-162025-07-162025Hatoum AS, Davis CN, Kember RL, et al. Concerns about genetic risk testing for opioid use disorder. Lancet Psychiatry. 2025;12(2):94-95. doi:10.1016/S2215-0366(24)00310-9https://hdl.handle.net/1805/49518en-USPublisher PolicyGenetic testingAddictive disorderRiskGenetic variantsOpioid use disorderConcerns About Genetic Risk Testing for Opioid Use DisorderArticle